INTRODUCTION:Electronic cigarettes (e-cigarettes) have the potential to significantly reduce exposure to harmful constituents associated with cigarette smoking when smokers completely substitute cigarettes with e-cigarettes. This study examined patterns of e-cigarette and cigarette use, and extent of toxicant exposure, if smokers were instructed and incentivized to completely switch to e-cigarettes compared to instructions to use the product ad libitum. AIMS AND METHODS: US adult daily smokers (n = 264; 49.2% female; Mage = 47.0), uninterested in quitting smoking immediately, were recruited from Minneapolis, MN, Columbus, OH, and Buffalo, NY. Participants were randomized to 8 weeks of instructions for (1) ad libitum use of e-cigarettes (AD-E), (2) complete substitution of cigarettes with e-cigarettes (CS-E), (3) complete substitution of cigarettes with nicotine gum or lozenge (CS-NRT), or (4) continue smoking of usual brand cigarettes (UB). Participants were incentivized for protocol compliance, including complete switching in the CS-E and CS-NRT groups. Outcome variables were cigarette smoking rate and tobacco-related biomarkers of exposure. RESULTS: Smokers in the CS-E and CS-NRT groups showed lower rates of smoking and lower exposure to carbon monoxide, tobacco carcinogens, and other toxicants than smokers in the AD-E group. In general, no significant differences were observed between CS-E versus CS-NRT or between AD-E versus UB for most biomarkers. Significantly higher 7-day point prevalence smoke-free rates were observed for CS-E versus CS-NRT. CONCLUSIONS: Smokers instructed and incentivized to completely switch to e-cigarettes resulted in lower smoking rates and greater reductions in exposures to harmful chemicals than smokers instructed to use the product ad libitum. IMPLICATIONS: Smokers instructed to completely substitute e-cigarettes for cigarettes displayed significantly lower levels of smoking and biomarkers of exposure to carcinogens and toxicants, compared to smokers instructed to use e-cigarettes ad libitum and similar levels as smokers instructed to completely substitute with nicotine replacement therapies. Furthermore, a higher rate of complete switching was achieved with e-cigarettes versus nicotine replacement therapies. Approaches to maximize complete substitution with e-cigarettes are an important area for future research.
RCT Entities:
INTRODUCTION: Electronic cigarettes (e-cigarettes) have the potential to significantly reduce exposure to harmful constituents associated with cigarette smoking when smokers completely substitute cigarettes with e-cigarettes. This study examined patterns of e-cigarette and cigarette use, and extent of toxicant exposure, if smokers were instructed and incentivized to completely switch to e-cigarettes compared to instructions to use the product ad libitum. AIMS AND METHODS: US adult daily smokers (n = 264; 49.2% female; Mage = 47.0), uninterested in quitting smoking immediately, were recruited from Minneapolis, MN, Columbus, OH, and Buffalo, NY. Participants were randomized to 8 weeks of instructions for (1) ad libitum use of e-cigarettes (AD-E), (2) complete substitution of cigarettes with e-cigarettes (CS-E), (3) complete substitution of cigarettes with nicotine gum or lozenge (CS-NRT), or (4) continue smoking of usual brand cigarettes (UB). Participants were incentivized for protocol compliance, including complete switching in the CS-E and CS-NRT groups. Outcome variables were cigarette smoking rate and tobacco-related biomarkers of exposure. RESULTS: Smokers in the CS-E and CS-NRT groups showed lower rates of smoking and lower exposure to carbon monoxide, tobacco carcinogens, and other toxicants than smokers in the AD-E group. In general, no significant differences were observed between CS-E versus CS-NRT or between AD-E versus UB for most biomarkers. Significantly higher 7-day point prevalence smoke-free rates were observed for CS-E versus CS-NRT. CONCLUSIONS: Smokers instructed and incentivized to completely switch to e-cigarettes resulted in lower smoking rates and greater reductions in exposures to harmful chemicals than smokers instructed to use the product ad libitum. IMPLICATIONS: Smokers instructed to completely substitute e-cigarettes for cigarettes displayed significantly lower levels of smoking and biomarkers of exposure to carcinogens and toxicants, compared to smokers instructed to use e-cigarettes ad libitum and similar levels as smokers instructed to completely substitute with nicotine replacement therapies. Furthermore, a higher rate of complete switching was achieved with e-cigarettes versus nicotine replacement therapies. Approaches to maximize complete substitution with e-cigarettes are an important area for future research.
Authors: Blair N Coleman; Brian Rostron; Sarah E Johnson; Bridget K Ambrose; Jennifer Pearson; Cassandra A Stanton; Baoguang Wang; Cristine Delnevo; Maansi Bansal-Travers; Heather L Kimmel; Maciej L Goniewicz; Raymond Niaura; David Abrams; Kevin P Conway; Nicolette Borek; Wilson M Compton; Andrew Hyland Journal: Tob Control Date: 2017-06-17 Impact factor: 7.552
Authors: Steven G Carmella; Xun Ming; Natalie Olvera; Claire Brookmeyer; Andrea Yoder; Stephen S Hecht Journal: Chem Res Toxicol Date: 2013-07-24 Impact factor: 3.739
Authors: Steven G Carmella; Menglan Chen; Adam Zarth; Stephen S Hecht Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2013-07-15 Impact factor: 3.205
Authors: Lion Shahab; Maciej L Goniewicz; Benjamin C Blount; Jamie Brown; Ann McNeill; K Udeni Alwis; June Feng; Lanqing Wang; Robert West Journal: Ann Intern Med Date: 2017-02-07 Impact factor: 25.391
Authors: Hayden McRobbie; Anna Phillips; Maciej L Goniewicz; Katie Myers Smith; Oliver Knight-West; Dunja Przulj; Peter Hajek Journal: Cancer Prev Res (Phila) Date: 2015-09
Authors: Mari S Gades; Ashley Petersen; Ellen Meier; Bruce R Lindgren; Richard J O'Connor; Peter G Shields; Dorothy Hatsukami Journal: Drug Alcohol Depend Date: 2020-04-25 Impact factor: 4.492
Authors: Caroline O Cobb; Jonathan Foulds; Miao-Shan Yen; Susan Veldheer; Alexa A Lopez; Jessica M Yingst; Christopher Bullen; Le Kang; Thomas Eissenberg Journal: Lancet Respir Med Date: 2021-04-12 Impact factor: 102.642
Authors: Lisa M Fucito; Krysten W Bold; Stephen R Baldassarri; John P LaVigne; Bennie Ford; Polly Sather; Stephanie S O'Malley; Benjamin A Toll Journal: Prev Med Rep Date: 2021-06-09